GL1X · GenesisL1 explorer

MolNFT v1 · #136254 · protein

The crystal structure of human O-glcnacase in complex with thiamet-G

5UN9 · Protein O-glcnacase: “The crystal structure of human O-glcnacase in complex with thiamet-G”. X-ray diffraction, 1 ligand (NHT), 5 pockets (best druggability 0.81). MolNFT v1 #136254 on GenesisL1: 3D structure, binding sites and…

PDB
5UN9
Type
protein
Length
844 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein O-glcnacase
EC
3.2.1.169, 3.2.1.-
UniProt
O60502
Ligands
NHT
Pockets
5 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 51% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein O-glcnacase (EC 3.2.1.169, 3.2.1.-)protein41850% helix, 9% strandO60502
BProtein O-glcnacase (EC 3.2.1.169, 3.2.1.-)protein42651% helix, 9% strandO60502

Ligands and binding sites

  • NHT · (3ar,5r,6s,7r,7ar)-2-(ethylamino)-5-(hydroxymethyl)-5, 6,7,7A-tetrahydro-3AH-pyrano[3,2-d][1,3]thiazole-6,7-diol · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19210.810.8377empty
23910.660.7945NHT
33110.590.7741NHT
4780.580.8817empty
5800.500.8425empty

Interfaces

1 interface between chains.

  • A–B · 3438 Ų buried · 31 hydrogen bonds · protein-protein

Compared structures

  • 5UN9 · The crystal structure of human O-GlcNAcase in complex with Thiamet-G · the same entry in another collection · chain A against A, TM-score 1.00
  • O60502 · AlphaFold monomer V2.0 prediction for protein O-glcnacase (O60502) · a predicted model of the same protein · chain B against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.